Medicines and Healthcare products Regulatory Agency
Regulatory Agency
Featured
MHRA approves GLP –1 receptor agonist semaglutide to reduce risk of serious heart problems in obese or overweight adults
Press release
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease
![](https://assets.publishing.service.gov.uk/media/669fcb6bab418ab055592bbf/s465_wegovy-new.png)
MHRA approves the first generic raltegravir medicines to treat adult and paediatric patients infected by HIV
Press release
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 19 July 2024, approved the first generic raltegravir medicines to treat adult and paediatric HIV patients who weigh at least 40kg.
![](https://assets.publishing.service.gov.uk/media/669a6b98ce1fd0da7b592938/s465_960_640.png)
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine capivasertib (Truqap) for patients with advanced hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer which has one or more abnormal “PIK3CA”, “AKT1”, or “PTEN” gene, and does not respond to other anti-hormonal-based therapies.
![](https://assets.publishing.service.gov.uk/media/6697e9dace1fd0da7b592798/s465_rsz_1istock-478022502_1_resized.jpg)
The Medicines and Healthcare products Regulatory Agency (MHRA) has today, 17 July 2024, approved the medicine vibegron (Obgemsa) to treat the symptoms of overactive bladder (OAB) syndrome in adults. Symptoms may include a sudden need to empty the bladder (urgency), urinating more frequently (urinary frequency), and urinary incontinence.
![](https://assets.publishing.service.gov.uk/media/6697e7fcfc8e12ac3edafed7/s465_960_640.png)
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved a new formulation of the medicine ocrelizumab (Ocrevus 920mg solution for injection) to treat relapsing forms of multiple sclerosis (RMS) and primary progressive multiple sclerosis (PPMS) in adults.
![](https://assets.publishing.service.gov.uk/media/669148e00808eaf43b50cec5/s465_iStock-174850638__960_x_640_.jpg)
A man who had unlicensed medicines sent to his parents’ address, has been sentenced at Southwark Crown Court to a term of imprisonment, having earlier been found guilty of criminal activity in May. The sentencing follows an investigation by the Medicine and Healthcare products Regulatory Agency’s Criminal Enforcement Unit (CEU) into the illegal supply of unlicensed medicines.
![](https://assets.publishing.service.gov.uk/media/6682cfba5b0d63b556a4b566/s465_Kolias.png)
Latest from the Medicines and Healthcare products Regulatory Agency
What we do
The Medicines and Healthcare products Regulatory Agency regulates medicines, medical devices and blood components for transfusion in the UK.
MHRA is an executive agency, sponsored by the Department of Health and Social Care.
Follow us
Documents
Transparency and freedom of information releases
Our management
![](https://assets.publishing.service.gov.uk/media/658195e2ed3c3400133bfb7d/s465_June-R-resized.png)
![](https://assets.publishing.service.gov.uk/media/6581968523b70a0013234bf6/s465_Amanda_C_edited.png)
![](https://assets.publishing.service.gov.uk/media/65819734ed3c3400133bfb82/s465_Graham-c-edited.png)
![](https://assets.publishing.service.gov.uk/media/6581982123b70a0013234bfe/s465_Micheal--edited.png)
![](https://assets.publishing.service.gov.uk/media/5a4f6cbeed915d5954734299/s465_liz-booth.jpg)
![](https://assets.publishing.service.gov.uk/media/65819583ed3c3400133bfb7a/s465_Rose-b-edited.png)
![](https://assets.publishing.service.gov.uk/media/658197aeed3c34000d3bfb8a/s465_Alison-C-edited.png)
![](https://assets.publishing.service.gov.uk/media/65819769fc07f300128d4483/s465_Claire-H-edited.png)
![](https://assets.publishing.service.gov.uk/media/658196ed23b70a000d234bfc/s465_Laura-S-retouch.jpg)
![](https://assets.publishing.service.gov.uk/media/658196b7fc07f300128d447e/s465_Glen-w-edited.png)
Contact MHRA
General enquiries
10 South Colonnade
London
E14 4PU
United Kingdom
Telephone
020 3080 6000
Fax
020 3118 9803
Office hours are Monday to Friday, 9am to 5pm.
Media enquiries
MHRA
10 South Colonnade
London
E14 4PU
United Kingdom
During office hours:
020 3080 7651 (08:30 - 17:00)
Out of office hours:
07770 446 189 (17:00 - 08:30)
Office hours are Monday to Friday, 8:30am to 5pm. For real-time updates including the latest press releases and news statements, see our Twitter channel at https://www.twitter.com/mhragovuk.
Make an FOI request
- Read about the Freedom of Information (FOI) Act and how to make a request.
- Check our previous releases to see if we’ve already answered your question.
- Make a new request by contacting us using the details below.
Freedom of Information
10 South Colonnade
London
E14 4PU
United Kingdom